Laurie Toich, Associate Editor

Cigna Corporation and Express Scripts have announced an agreement in which Cigna will purchase the pharmacy benefit manager (PBM) for $67 billion, which includes $15 billion in Express Scripts debt.

Cigna to acquire major pharmacy benefit manager for $67 billion.

New research may overcome hurdles to eliminating viral reservoirs that prevent curing HIV.

Patients between 18 and 24 years of age with IBD may have a greater risk of heart attacks.

Malignant peripheral nerve sheath tumors are currently incurable.

First Abbreviated New Drug Application filed for sofosbuvir (Sovaldi).

Younger patients with IBD may be at a high risk of experiencing a heart attack.

FDA approves shorter administration periods and new dosing options for nivolumab (Opdivo).

Research into gene variants may improve targeted treatments for pancreatic cancer.

A new direct-to-consumer test analyzes saliva for 3 BRCA variants that may elevate the risk of various types of cancer.

Mylan will reduce the wholesale acquisition costs of Smyfi Lo and Cimduo, which are both combination therapies for HIV.

Targeting an energy-related molecule could prevent the onset of autoimmune diseases.

A new direct-to-consumer test analyzes saliva for 3 BRCA variants that may elevate the risk of various types of cancer.

HIV packages a key viral protein in exosomes to transport throughout the body.

An enzyme blockade could assist remyelination in patients with peripheral nerve damage.

Stem cell treatments improved muscle strength and disability among patients with multiple sclerosis.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Daclizumab (Zinbryta) may cause brain inflammation among patients with relapsing multiple sclerosis.

Biologic drug demonstrates efficacy in moderate-to-severe asthma.

Patients with colon cancer who regularly consumed tree nuts had a 46% improvement in disease-free survival.

Sanofi recently announced that the FDA has accepted the supplemental Biologics License Application (sBLA) of dupilumab (Dupixent) for the maintenance treatment of asthma.

The FDA advises patients to be cautious when purchasing influenza drugs online.

Current treatments for neurofibromatosis tumors may result in drug resistance.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Officials with the FDA have issued a statement warning Consumers to be wary of unapproved products that claim to prevent, treat, or cure influenza.

Increase in Merkel cell carcinoma cases outpaces the rate of melanoma.

The US Preventive Services Task Force recommends against ovarian cancer screening.

ERK inhibitors may increase the efficacy of other anti-cancer drugs.